We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Novo Integrated Sciences Inc (NVOS) USD0.001

Sell:$1.30 Buy:$1.39 Change: $0.035 (2.64%)
Market closed |  Prices as at close on 26 November 2021 | Switch to live prices |
Change: $0.035 (2.64%)
Market closed |  Prices as at close on 26 November 2021 | Switch to live prices |
Change: $0.035 (2.64%)
Market closed |  Prices as at close on 26 November 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Novo Integrated Sciences, Inc. offers multidisciplinary primary health care related services and products. The Company operates through its subsidiary, Novo Healthnet Limited (Nova). Novo provides its services and products through both clinic and eldercare related operations. Nova’s services include physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and baseline testing, women’s pelvic health programs, sports medicine therapy, assistive devices, dietitian, holistic nutrition, fall prevention education and private personal training. It also provides nutraceutical health solutions. The Company’s subsidiaries also include Novo Assessments, Inc., Novo Healthnet Rehab Limited, Novomerica and an 80% interest in Novo Healthnet Kemptville Centre, Inc.

Contact details

11120 NE 2ND STREET, SUITE 100
United States
+1 (206) 6179797

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$35.10 million
Shares in issue:
26.49 million
Health Care Services
United States
US dollar

Key personnel

  • Robert Mattacchione
    Chairman of the Board, Chief Executive Officer
  • Christopher David
    President, Director of Novo Integrated Sciences, Inc.
  • James Zsebok
    Principal Financial Officer, Principal Accounting Officer
  • Klara Radulyne
    Principal Financial Officer
  • James Asher
    President - Novo Healthnet Limited
  • Thomas Barus
    Executive Vice President - Technology, Novo Healthnet Limited
  • Christopher Wade
    Executive Vice President - Strategy and Operations, Novo Healthnet Limited
  • Indrajit Sinha
    Chief Science Officer
  • Michael Gaynor
    Secretary, Director

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.